TA
THC icon

Tamarack Advisers’s Tenet Healthcare THC Stock Holding History

Tamarack Advisers’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,000
Closed -$1.32M – 17
2023
Q3 		$1.32M Sell
20,000
-75,000
-79% -$5.61M 0.85% 18
2023
Q2 		$7.73M Sell
95,000
-5,000
-5% -$356K 2.39% 7
2023
Q1 		$5.94M Buy
100,000
+5,000
+5% +$278K 2.17% 11
2022
Q4 		$4.64M Sell
95,000
-80,000
-46% -$3.7M 2.39% 15
2022
Q3 		$9.03M Buy
175,000
+15,000
+9% +$890K 5.3% 5
2022
Q2 		$8.41M Buy
160,000
+85,000
+113% +$5.92M 4.87% 5
2022
Q1 		$6.45M Sell
75,000
-125,000
-63% -$10.3M 3.05% 13
2021
Q4 		$16.3M Buy
200,000
+125,000
+167% +$9.14M 6.72% 1
2021
Q3 		$4.98M Buy
+75,000
New +$5.32M 1.57% 23

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tamarack Advisers's THC Position: Q4 2023 in Review

Tamarack Advisers sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 20,000 shares — an estimated $1.32M sold.

Tamarack Advisers first reported a position in THC in Q3 2021 and held it in 9 quarters. The position peaked at $16.3M in Q4 2021. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

  • Tamarack Advisers reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
  • Tamarack Advisers sold 20,000 Tenet Healthcare shares in Q4 2023, an estimated $1.32M.
  • Tamarack Advisers first reported a position in Tenet Healthcare in Q3 2021 and held it in 9 quarters.
  • Tamarack Advisers's Tenet Healthcare position peaked at $16.3M in Q4 2021.
  • 425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Tamarack Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.